Rocket Pharmaceuticals (RCKT) Tops Q4 EPS by 14c
Tweet
Share
E-mail
Get Alerts RCKT Hot Sheet
Join SI Premium – FREE
Rocket Pharmaceuticals (NASDAQ: RCKT) reported Q4 EPS of ($0.64), $0.14 better than the analyst estimate of ($0.78).
For earnings history and earnings-related data on Rocket Pharmaceuticals (RCKT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- BIG3 Basketball to go public via Graf Global merger at $290 million
- UBS Reiterates Neutral Rating on Lennar (LEN) Following Q2 Results
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
